Brand comparison
Shed vs MEDVi
Short answer: both sell compounded GLP-1 treatment online, and the difference is in the terms. Shed's compounded tirzepatide is $299 a month month to month, or $239 a month on a twelve-month commitment, the figure its banner advertises, and its current terms let you cancel at any time (prices read from Shed's product page, checked 29 October 2026; terms re-read 1 November 2026). MEDVi lists compounded GLP-1 injections at an introductory $99 for the first month, then $199 for refills, with no membership and a 72-hour cooling-off refund (checked 31 October 2026). Shed states it serves all 50 states and names no pharmacy; MEDVi names three pharmacies and no states. Compounded medicines are not FDA-approved.
For anyone comparing two compounded GLP-1 programmes on price, commitment and refund terms. Every figure is read from each provider's own pages, with the date.
Quick editorial read
Shed and MEDVi both sell compounded GLP-1 treatment with no membership fee. Shed's advertised figure is a twelve-month rate, its current terms let you cancel at any time, and it has a conditional 120-day refund promise and a stated 50-state footprint; MEDVi's is a first-month introductory price with no minimum term, a 72-hour cooling-off refund, three named pharmacies and an FDA warning letter on record. This page sets out what each states. It does not rank one above the other.
Shed vs MEDVi: the facts side by side
Two compounded GLP-1 programmes with no membership fee. The differences are commitment length, refund terms and what each names.
| Shed | MEDVi | |
|---|---|---|
| Advertised price | Compounded tirzepatide $299 a month month to month, or $239 a month on a twelve-month commitment (the "starting as low as" banner figure); compounded semaglutide $199 month to month or $159 on twelve months (checked 29 October 2026) | Compounded GLP-1 injections: an introductory $99 for the first month, then $199 for refills (checked 31 October 2026) |
| How the price is structured | Three tiers by commitment: one, six and twelve months, with the advertised figure the twelve-month rate; billing every 28 days or monthly depending on the programme | A first-month introductory price, then a refill price MEDVi says is "locked in"; no plan length required |
| Price as the dose rises | Shed states the price stays the same if your provider increases the dose | Not stated either way |
| Membership fee | None on the compounded injections; a separate monthly membership applies to the branded and oral options | None on the compounded plans, as MEDVi states; branded routes are a membership plus the medication |
| Medication | Compounded semaglutide and compounded tirzepatide injections, a microdose line, and branded options; compounded medications are not FDA-approved, as Shed states | Compounded GLP-1 injections and tablets; not FDA approved, as MEDVi states |
| Minimum term | None in its current terms (re-read 1 November 2026): cancel at any time, effective when submitted; multi-month plans reprice shipped fills at the month-to-month rate | None stated; monthly plans can be cancelled with 72 hours' notice before the next billing date |
| Cancellation and refunds | Cancel at any time in the patient portal, by email or through any billing email; fees already charged are refunded only in listed cases (not eligible at enrolment, provider stops treatment before the fill ships, unshipped multi-month fills). A 120-day refund promise exists for first-time users who meet all four of its conditions (terms re-read 1 November 2026) | Cancel at least 72 hours before the next billing date; full refund within the first 72 hours before any service, or on medical disqualification; no refund for the month of cancellation on a monthly plan |
| Who prescribes | An independent provider group; Shed's terms say providers furnish care only in states where they hold an active, unrestricted licence | OpenLoop Health clinicians, in a consultation after checkout |
| Pharmacy | Not named | Three named: Triad Rx, Red Rock Home Pharmacy and Beaker Pharmacy |
| States served | Shed states telehealth in all 50 states, with treatment availability varying by state | Not published |
| Insurance | Not needed; eligible treatments can be paid with HSA or FSA funds, as Shed states | Not required on the compounded plans; HSA/FSA approved, as MEDVi states |
| FDA warning letter | None found in our Shed review; Shed names no pharmacy to check | 721455, 20 February 2026, on the labelling and marketing of its compounded GLP-1 products; no close-out shown on 18 October 2026 |
| Third-party ratings | Our Shed review records no Trustpilot or BBB reading, and Shed names no review platform on its site | Trustpilot 4.3 from 15,102 reviews (read 26 October 2026); BBB F, 782 complaints in three years (read 22 October 2026) |
Prices from each provider's own pages, read daily into our archive; the dates shown are the latest read. Shed's terms were read on 20 September 2026 and MEDVi's on 16 September 2026, with its public record read on the dates given. Compounded medicines are not FDA-approved.
Starting at
$199/mo
semaglutide, month to month
Tirzepatide, month to month $299/mo, Sermorelin $199/mo, Semaglutide, 12-month plan $159/mo, Tirzepatide, 12-month plan $239/mo, plus 2 more treatments
Checked 29 Oct 2026.
US telehealth platform for GLP-1 plus longevity, hair and sexual-health treatments.
- Treatments
- Weight management, Longevity, Hair, Sexual health
- Available
- All 50 states, treatment varies
- Pricing
- Published, checked 29 Oct 2026
Compounded GLP-1 injections, including tirzepatide, and tablets, plus branded routes.
- Treatments
- Compounded GLP-1 injections, Compounded tirzepatide, Compounded GLP-1 tablets, Branded GLP-1
- Available
- US, varies by state
- Pricing
- Published, checked 31 Oct 2026
At-a-glance comparison
Shed
Full profile- Best for
- Buyers who want one provider for weight management, longevity, hair and sexual health, and who will read the commitment length before reading the price. Shed publishes a wider menu than most, with six longevity treatments, seven hair products and five for sexual health, and prices nearly all of them. It suits nobody who takes the advertised "from" price at face value: that is the twelve-month rate, month-to-month costs more, and billing runs every 28 days.
- Pricing
- Compounded semaglutide is $199 a month on a one-month plan and $159 a month on a twelve-month plan; compounded tirzepatide is $299 and $239 on the same two (read from Shed's product pages, checked 29 October 2026). Microdose compounded semaglutide is from $149 a month and microdose tirzepatide from $199, with a 2-month minimum on the tirzepatide. Brand-name medication is a separate charge on top of a $125 a month Shed Membership: Foundayo (the oral GLP-1) from $149 a month, Wegovy from $149 as a pill or $199 as a pen, and Zepbound from $299 as a vial (Shed's product pages, checked 1 November 2026).
- Access
- Weight management: compounded semaglutide and tirzepatide injections, microdose versions of both, GLP-1 liquid drops, GLP-1 lozenges, Foundayo (oral orforglipron), Wegovy, Zepbound, Ozempic, Mounjaro, metformin with naltrexone and topiramate, and MIC + B12 injections. Longevity: NAD+ as injection, nasal spray or oral tablet, glutathione, sermorelin, low-dose naltrexone, methylene blue and microdose GLP-1. Hair: minoxidil and finasteride serums, 3-in-1 and 5-in-1 formulations for men and women, and a copper peptide (GHK-Cu) serum. Sexual health: Rise, Steady, Extend, Desire and Euphoria.
MEDVi
Full profile- Best for
- Buyers who want the supply chain written down before they pay. MEDVi is one of the few programmes at this price point that names its partner pharmacies, names the prescriber network, and publishes a full cancellation and refund policy. It also suits people weighing a compounded plan against a branded one on the same platform, since it prices both.
- Pricing
- Compounded GLP-1 injections are an introductory $99 for the first month and $199 for refills (checked 31 October 2026). Compounded GLP-1 tablets start at $249, with no period stated on the card (checked 1 November 2026). Branded routes are sold differently, as a $99 membership plus the cost of the medication itself (checked 1 November 2026). MEDVi states there is no membership fee or hidden fee on the compounded plans, that no insurance is required, that shipping is free, and that the plans are HSA/FSA approved.
- Access
- Compounded GLP-1 injections and tablets, plus branded GLP-1 routes sold as a membership plus medication cost. Prescriptions are issued only after an online consultation with an independent licensed provider. MEDVi states that compounded medications are dispensed by state-licensed pharmacies but are not FDA approved, and that although the facilities are FDA-regulated the medicines are not FDA-approved or evaluated for safety, efficacy or quality.
Is Shed or MEDVi cheaper?
For the first month, MEDVi's introductory $99 is the lower figure. After that MEDVi's refills are $199 (checked 31 October 2026), against Shed's compounded tirzepatide at $299 a month month to month; Shed's advertised "starting as low as" $239 applies only on a twelve-month commitment, and the full table, with the six-month tier, is in our Shed review (prices checked 29 October 2026). MEDVi's refill figure is for its GLP-1 injections plan and does not name the molecule; Shed's is tirzepatide specifically, so the two are not strictly like for like.
Shed states its price does not rise when the dose does; MEDVi says refills are locked in and says nothing about dose. For both over 3, 6 and 12 months, read daily, see the US GLP-1 price index.
Commitment and refunds: cancel any time against the 72-hour window
Shed's current terms, re-read on 1 November 2026, let you cancel at any time, effective when you submit it, and bill every 28 days, which is thirteen charges a year. The terms we read on 20 September 2026 set a two-month minimum; that is gone. Fees already charged are refunded only in the cases the terms list. Shed's 120-day promise refunds what you paid only if you are a first-time user of the medication class, meet all four member commitments, and reach neither 5% weight loss nor your recorded goal weight within 120 days.
MEDVi sets no minimum term. Its policy gives a full refund if you cancel within the first 72 hours before receiving any service, or if a clinician disqualifies you for a medical reason, and no refund for the month of cancellation on a monthly plan; cancellation requests must arrive at least 72 hours before the next billing date.
States, pharmacies and the public record
Shed states it offers telehealth in all 50 states, with treatment availability varying by state, and its terms add that providers furnish care only where they hold a licence. MEDVi does not publish the states it serves. The pattern reverses on pharmacies: MEDVi names Triad Rx, Red Rock Home Pharmacy and Beaker Pharmacy, while Shed names none.
On the public record, MEDVi has an FDA warning letter (721455, 20 February 2026) over the marketing of its compounded products, a Trustpilot score of 4.3 from 15,102 reviews (read 26 October 2026) and an F from the BBB with 782 complaints in three years (read 22 October 2026). Our Shed review records no FDA letter and no third-party rating, and Shed names no review platform on its site, so the member counts and outcome figures it publishes are its own. Absence of a record is not a clean record; it is an absence.
How to choose
Shed and MEDVi both sell compounded GLP-1 treatment with no membership fee. Shed's advertised figure is a twelve-month rate, its current terms let you cancel at any time, and it has a conditional 120-day refund promise and a stated 50-state footprint; MEDVi's is a first-month introductory price with no minimum term, a 72-hour cooling-off refund, three named pharmacies and an FDA warning letter on record. This page sets out what each states. It does not rank one above the other.
The right provider is the one that can explain eligibility, costs, side effects, refills, and support before you commit. Avoid treating GLP-1 access as a generic checkout flow; consultation is required and availability varies.
Pricing and access
Shed: compounded tirzepatide $299 a month month to month, or $239 on a twelve-month commitment, the rate its banner advertises (checked 29 October 2026). MEDVi: an introductory $99 for the first month of compounded GLP-1 injections, then $199 for refills, with no membership fee on the compounded plans (checked 31 October 2026).
Compounded medication at both: Shed's compounded semaglutide and tirzepatide injections and microdose line, MEDVi's compounded GLP-1 injections and tablets. Both state that compounded medicines are not FDA-approved, and both also list branded options sold as a membership plus the medication. A licensed clinician decides whether to prescribe.
Users comparing local care can also review PCF city hubs such as Miami, New York, and Los Angeles.
Each provider has its own review: the Shed review sets out its full price table by commitment length, its cancellation terms and its 120-day promise, and the MEDVi review sets out its introductory and refill prices, its three pharmacies, its refund policy and the FDA warning letter.
Consultation, delivery, and follow-up
Both begin with an online intake and a clinician decision. At MEDVi an OpenLoop Health clinician consults with you after checkout and MEDVi refunds in full on medical disqualification. At Shed an independent provider group decides, and Shed refunds the initial fee in full if you are found ineligible at enrolment.
Both include standard shipping at no extra cost, as each states. MEDVi ships from one of its three named pharmacies; Shed does not name the pharmacy that fills its orders.
If a provider cannot clearly explain who reviews your intake, how side effects are handled, or what happens when your refill is due, keep comparing before you proceed.
Shed
Shed is the widest published menu among the US programmes listed here, and the one whose own pages are most likely to quote a reader the wrong number. Both facts belong in the same sentence. The menu is real and mostly priced; the prices need reading twice, because the site repeats four navigation figures on every page, shows a templated $149 on individual product pages regardless of the product, and leads with twelve-month rates. A buyer who checks the commitment length and the 28-day billing cycle before signing up is getting a broad, competitively priced service. One who does not may pay $40 a month more than they expected.
Pros
- Unusually wide published menu: weight management, longevity, hair and sexual health
- Prices published for 20 of its 26 named treatments
- Price held flat when a provider raises the dose
- Standard shipping included; HSA and FSA accepted
- Cancel at any time, effective when you submit it (terms re-read 1 November 2026)
Considerations
- Headline GLP-1 prices are twelve-month rates, not the month-to-month cost
- Billing runs every 28 days, so thirteen charges a year
- The 120-day guarantee excludes anyone who has used the medication class before
- The compounding pharmacy is not named
MEDVi
MEDVi is the strongest option on this list for a buyer who wants to know who compounds the medicine, who prescribes it and what happens if they stop. The disclosure is genuinely better than its competitors'; the refund terms, once read, are tighter than the marketing implies.
Pros
- Unusually complete disclosure: pharmacies, prescriber network, medical entity and refund terms are all published
- Both compounded and branded routes priced on the same platform, so the two can be compared directly
- Full refund if a clinician disqualifies you on medical grounds
- 24/7 support and a patient portal for messaging and progress tracking
Considerations
- No refund for the month in which you cancel, or for any prior month, on a monthly plan
- Cancellation must reach support at least 72 hours before the next billing date or the next cycle is charged
- Care coaching and dietician visits are qualified as "subject to insurance and copays eligibility", so "included" is conditional
- Several advertised categories, peptides and longevity, women’s health, hair, skin and supplements, are marked "coming soon" rather than available (checked 18 September 2026)
- Marketing carries large self-reported outcome figures that MEDVi's own footnote describes as not typical
Related research paths
Frequently asked questions
Is Shed or MEDVi cheaper?
For the first month MEDVi's introductory $99 is lower; its refills are then $199 (checked 31 October 2026). Shed's compounded tirzepatide is $299 a month month to month; the advertised "starting as low as" $239 is its twelve-month commitment rate (checked 29 October 2026). Confirm the plan length and the ongoing figure with each before you pay.
Does Shed have a minimum commitment?
No, not any more. Shed's current terms (re-read 1 November 2026) state there is no minimum commitment: you can cancel at any time, effective when you submit it, and multi-month plans reprice shipped fills at the month-to-month rate if you stop early. The terms we read on 20 September 2026 set a two-month minimum. MEDVi states no minimum term.
Does MEDVi have a money-back guarantee like Shed?
No. MEDVi's policy refunds in full if you cancel within the first 72 hours before receiving any service, or if a clinician disqualifies you for a medical reason, and states there is no guarantee of results. Shed's 120-day promise refunds what you paid only to first-time users who meet all four of its member commitments and reach neither 5% weight loss nor their recorded goal weight (Terms effective 10 June 2026).
Are Shed and MEDVi medications FDA-approved?
The compounded medications are not, and both providers say so. Each also lists branded, FDA-approved options sold as a membership plus the medication. MEDVi received FDA warning letter 721455 in February 2026 over the marketing of its compounded products; our Shed review records no FDA letter, and Shed names no pharmacy whose record could be checked.
Which states do Shed and MEDVi serve?
Shed states it offers telehealth in all 50 states, with treatment availability varying by state and providers furnishing care only where licensed. MEDVi does not publish a list of states. Both say eligibility is decided by a licensed clinician.
Editorial transparency
PCF separates clinical information from sponsored links. Some provider links may be sponsored, but all providers are described with cautious medical language: treatment may be available, consultation is required, and clinical appropriateness is determined by a licensed professional.
Provider details can change. Before starting any program, verify the current price, medication path, clinician credentials, pharmacy process, shipping terms, and follow-up support directly with the provider.